52 filings
8-K
FEMY
Femasys Inc
9 May 24
Results of Operations and Financial Condition
8:35am
8-K
FEMY
Femasys Inc
24 Apr 24
Regulation FD Disclosure
9:11am
8-K
FEMY
Femasys Inc
28 Mar 24
Results of Operations and Financial Condition
4:23pm
8-K
FEMY
Femasys Inc
20 Mar 24
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility
8:18am
8-K
FEMY
Femasys Inc
6 Mar 24
Femasys Completes the First In-Office Commercial Procedure with the FDA-Cleared FemaSeed Infertility Solution
9:09am
8-K
2359qpv1
28 Feb 24
Disrupting Convention in Women’s Health Through Continuous Innovation February 2024 Corporate Presentation 1
9:16am
8-K
icqbw xhn5ifh
6 Feb 24
Femasys Inc. Advances Commercial Readiness with Appointment of Richard Spector to New Position of Chief Commercial Officer
8:47am
8-K
4c2nucr2l5uqb04wjj
29 Nov 23
Femasys Inc. Completes Enrollment of FemaSeed Pivotal Trial in Support of Commercial Launch
4:05pm
8-K
gqf22i9z4u7srnmg
21 Nov 23
Departure of Directors or Certain Officers
5:30pm
8-K
b9p8017lbrey4n5m6a74
15 Nov 23
Femasys Inc. Secures Additional Financing with Strategic Investment from Investors led by PharmaCyte Biotech
5:19pm
8-K
5a6jlqj
14 Nov 23
Femasys Inc. Announces Financial Results for the Third Quarter Ended
12:00am
8-K
uhr23xm
11 Oct 23
Other Events
8:01am
8-K
cs8o32 7sr4m
3 Oct 23
Other Events
9:28am
8-K
fvfc7f0k p746q
27 Sep 23
Disrupting Convention in Women’s Health Through Continuous Innovation September 2023 Corporate Presentation 1
8:19am
8-K
ro6bgzk9glqjdkn
6 Sep 23
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
rl38fyvk pcfl2
10 Aug 23
Femasys Inc. Announces Financial Results for the Second Quarter Ended Second Quarter 2023 Financial Results
8:05am
8-K
8kw75v
3 Aug 23
Femasys Initiates Enrollment in Pivotal Trial of its Permanent Birth Control Candidate FemBloc
9:04am
8-K
cpfrr8k
27 Jul 23
Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemBloc for Female Permanent Birth Control
9:04am
8-K
uuece3ec
26 Jun 23
Disrupting Convention in Women’s Health Through Continuous Innovation June 2023 Corporate Presentation 1
8:05am
8-K
8k7uvt
21 Jun 23
Submission of Matters to a Vote of Security Holders
5:18pm